Pharvaris N.V. (PHVS) Form 10-Q Quarterly Reports
Pharvaris N.V. (PHVS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PHVS
CIK: 1830487
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers Accountants N.V.
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerWillem Voorthuijsen
Audit LocationAmsterdam, Netherlands
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-11 | 4 | 0001193125-26-420425 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001193125-26-402567 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | 4 | 0001193125-26-401007 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | 4 | 0001193125-26-400435 | View SEC Doc Filr Page |
| 144 | 2026-09-23 | — | 144 Filing | 0001950047-26-009773 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 | 0001193125-26-398678 | View SEC Doc Filr Page |
| 144/A | 2026-09-22 | — | 144/A Filing | 0001950047-26-009752 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009744 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396695 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396689 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001950047-26-009695 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396584 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396579 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396572 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 | 0001193125-26-396565 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009655 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009654 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009653 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009647 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009617 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009612 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394103 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-393860 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 | 0001193125-26-392895 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009540 | View SEC Doc Filr Page |